Nitric oxide synthase inhibitor L-NAME prevents amphetamine-induced prodynorphin gene expression in the rat

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 7, 1996, Pages 1229-1237

  Przewłocka, Barbara ^a   Turchan, Jadwiga ^a   Machelska, Halina ^a   Łabuz, Dominika ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

amphetamine; L NAME; nucleus accumbens; prodynorphin mRNA; rat; striatum

Indexed keywords

AMPHETAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRODYNORPHIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; STEREOTYPY;

AMPHETAMINE; ANIMALS; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RNA, MESSENGER; STEREOTYPED BEHAVIOR;

EID: 0030272957     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(96)00108-X     Document Type: Article

References (29)

1. BALS-KUBIK R., HERZ A. and SHIPPENBERG T.S. (1989) Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated. Psychopharmacol. 98, 203-206.
2. BOZARTH M.A., PUDIAK C.M. and MORRIS M. (1994) Nitric oxide synthesis inhibition does not affect brain stimulation reward. Pharmacol. Biochem. Behav. 48, 487-490.
3. GNitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circn. Res. 72, 387-395.
4. COLE, R.L., KONRADI, C., DOUGLASS, J. and HYMAN, S.E. (1995) Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823.
5. DAUNAIS J.B., ROBERTS D.C.S. and McGINTY J.F. (1993) Cocaine self-administration increases prodynorphin but not c-fos mRNA in rat striatum. NeuroReport 4, 543-546.
6. DiCHIARA G. and IMPERATO A. (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244, 1067-1080.
7. EAST S.J. and GARTHWAITE J. (1991) NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine - nitric oxide pathway. Neurosci. Lett., 123, 17-19.
8. GAWIN F.H. (1991) Cocaine addiction: psychology and neurophysiology. Science 251, 1580-1586.
9. 3H-dopamine from striatal slices. NeuroReport 3, 409-412.
10. HANSON G.R., MERCHANT K.M., LETTER A.A., BUSH L. and GIBB J.W. (1988) Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur.J.Pharmacol. 155, 11-18.
11. HURD Y.L., BROWN E.E., FINLAY J.M., FIBIGER H.C. and GERFEN C.R. (1992) Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13, 165-170.
12. IZUMI Y., BENZ A.N., CLIFFORD D.B. and ZORUMSKI C.F. (1992) Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitoxicity in rat hippocampal slices. Neurosci. Lett. 135, 227-230.
13. JIANG H.K., McGINTY J.F. and HONG J.S. (1990) Differential modulation of striato-nigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 507, 657-664.
14. KARLER R., CALDER L.D., CHAUDHRY I.A. and TURCANIS S.A. (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801, Life Sci., 45, 599-606.
15. G-nitro-L-arginine prevents morphine tolerance, Eur. J. Pharmacol. 221, 399-400.
16. MAJEED N.H., PRZEWŁOCKA B., MACHELSKA H. and PRZEWŁOCKI R. (1994) Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacol. 33, 189-192.
17. MONCADA S., PALMER R.M.J. and HIGGS E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43, 109-140.
18. MORGAN J.I. and CURRAN T. (1991) Stimulus-transcription coupling in nervous sytem: involvement of the inducible protooncogenes fos and jun. Ann. Rev. Neurosci. 14, 421-451.
19. MORRIS B.J., HÖLLT V. and HERZ A. (1988) Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA. Neuroscience 25, 525-532.
20. MUCHA R.F. and HERZ A. (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning procedures. Psychopharmacol. 86, 274-280.
21. PRZEWŁOCKA B., LASOŃ W., MACHELSKA H. and PRZEWŁOCKI R. (1994) The effects of cocaine-induced seizures on the proenkephalin mRNA level in the mouse hippocampus: A possible involvement of the nitric oxide pathway. Neurosci. Lett. 168, 81-84.
22. PUDIAK C.M. and BOZARTH M.A. (1993) L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effects of cocaine. Life Sci. 53, 1517-1524.
23. SINGH N.A., MIDGLEY L.P., BUSH L.G., GIBB J.W. and HANSON G.R. (1991) N-methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems. Brain Res. 555, 233-238
24. SMITH A.J.W. and McGINTY J.F. (1994) Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res. 21, 359-362.
25. SPANAGEL R., ALMEIDA O.F.X., BARTL C. and SHIPPENBERG T.S. (1994) Endogenous κ-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacol. 115, 121-127.
26. SPANGLER R., UNTERWALD E.M. and KREEK M.J. (1993) "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19, 323-327.
27. UNTERWALD E.M., HORNE-KING J. and KREEK M.J. (1992) Chronic cocaine alters brain mu opioid receptors. Brain Res. 584, 314-318.
28. ZHU X.-Z. and LUO L.-G. (1992) Effect of nitroprusside (nitric oxide) on endogenous dopamine release from striatal slices. J. Neurochem. 59, 932-935.
29. YOUNG III W.S., BONNER T.I. and BRANN M.R. (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA, 83, 9827-9831.